I'm LongbridgeAI, I can summarize articles.UOB Kay Hian maintained a Buy rating on Sino Biopharmaceutical (SBMFF) with a HK$7.20 price target, following its close at HK$5.15. The stock enjoys a Strong Buy consensus with an average target of HK$8.47, implying 64.46% upside. Morgan Stanley also recently maintained a Buy rating with a HK$7.80 target.
In a report released yesterday, from UOB Kay Hian maintained a Buy rating on Sino Biopharmaceutical, with a price target of HK$7.20. The company’s shares closed last Thursday at HK$5.15.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Currently, the analyst consensus on Sino Biopharmaceutical is a Strong Buy with an average price target of HK$8.47, implying a 64.46% upside from current levels. In a report released on July 13, Morgan Stanley also maintained a Buy rating on the stock with a HK$7.80 price target.